Virologic outcomes in early antiretroviral treatment: HPTN 052
Susan H. Eshleman(Johns Hopkins University), Jessica M. Fogel(Johns Hopkins University), Myron S. Cohen(University of North Carolina at Chapel Hill), Joseph J. Eron(University of North Carolina at Chapel Hill), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Kenneth H. Mayer(Miriam Hospital), Lisa Mills(Kenya Medical Research Institute), Xinyi C. Zhang(University of North Carolina at Chapel Hill), Estelle Piwowar‐Manning(Johns Hopkins University), Nuntisa Chotirosniramit(Chiang Mai University), San‐San Ou, Ben Kalonga(University of Malawi), Marybeth McCauley(Family Health International 360), Joel E. Gallant(Johns Hopkins University), Ravindre Panchia(Chris Hani Baragwanath Hospital), Emily Shava(Botswana Harvard AIDS Institute Partnership), Ethan Wilson(Fred Hutch Cancer Center), Theresa Gamble(University of Utah), José Henrique Pilotto(Universidade Iguaçu), Ying Qing Chen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Noluthando Mwelase(University of the Witwatersrand), Sheela Godbole(The Ohio State University Wexner Medical Center), Nagalingeswaran Kumarasamy(University of North Carolina at Chapel Hill), Mina C. Hosseinipour, James Hakim(University of Zimbabwe), Breno Santos(Hospital Nossa Senhora da Conceição)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy
|Science|1997|3.1k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k